Revenue
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
DarioHealth Corp. (DRIO)
Price$6.99Cached quote
Net income
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.4M | $27.0M | $20.4M | $27.7M | $20.5M | $7.6M | $7.6M | $7.4M | $5.2M | $2.8M | $823,000 | $51,000 | $0 | — |
| Gross profit | $12.7M | $13.3M | $6.0M | $9.7M | $4.0M | $2.5M | $2.6M | $1.8M | $1.3M | −$830,000 | −$855,000 | −$2.7M | $0 | — |
| Gross margin | 56.64% | 49.06% | 29.40% | 34.91% | 19.32% | 33.17% | 34.36% | 23.87% | 25.36% | −29.61% | −103.89% | −5,317.65% | — | — |
| Research & development | $13.8M | $24.2M | $20.2M | $19.6M | $17.2M | $4.4M | $3.7M | $3.7M | $3.3M | $2.2M | $2.6M | $3.9M | $4.9M | $1.5M |
| Operating expenses | $49.3M | $71.0M | $62.2M | $66.5M | $80.5M | $32.4M | $20.3M | $19.5M | $15.7M | $10.3M | $6.8M | $8.6M | $13.6M | — |
| Operating income | −$36.7M | −$57.7M | −$56.2M | −$56.8M | −$76.5M | −$29.9M | −$17.7M | −$17.7M | −$14.4M | −$11.1M | −$7.7M | −$11.4M | −$13.6M | −$4.0M |
| Operating margin | −163.94% | −213.55% | −276.09% | −205.42% | −372.90% | −394.71% | −234.22% | −239.22% | −278.90% | −396.04% | −935.36% | −22,270.59% | — | — |
| EBITDA | −$33.5M | −$50.3M | −$51.2M | −$52.1M | −$72.0M | −$29.7M | −$17.5M | −$17.5M | −$14.2M | −$10.7M | −$7.4M | −$10.8M | −$12.7M | −$4.0M |
| EBITDA margin | −149.90% | −186.08% | −251.59% | −188.36% | −351.18% | −392.20% | −231.80% | −236.42% | −275.13% | −382.23% | −894.65% | −21,194.12% | — | — |
| Net income | −$41.7M | −$42.7M | −$59.4M | −$62.2M | −$76.8M | −$29.4M | −$17.7M | −$17.8M | −$15.7M | −$10.9M | −$7.1M | −$12.9M | −$13.9M | −$5.7M |
| Net profit margin | −186.56% | −158.09% | −292.00% | −224.88% | −374.21% | −388.66% | −234.63% | −240.78% | −304.51% | −388.41% | −867.80% | −25,249.02% | — | — |
| Basic EPSper basic share | $10.12 | $12.27 | $38.60 | $50.80 | $81.40 | $80.20 | $160.00 | $312.60 | $656.00 | $836.00 | $1,536.00 | $13,320.00 | $27,360.00 | $16,560.00 |
| Diluted EPSper diluted share | $10.12 | $12.27 | $38.60 | $50.80 | $81.40 | $80.20 | $160.00 | $312.60 | $656.00 | $836.00 | $1,536.00 | $13,320.00 | $27,360.00 | $16,560.00 |
Owners
Reported shareholders
16.64%of listed shares
Nantahala Capital Management, LLC1.22M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
Nantahala Capital Management, LLC | 16.64%1.22M shares |
Raphael Erez | —158.75K shares |
KAPLAN JON H. | ≈1.52%111.57K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.89%65.68K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.79%58.04K shares |
BlackRock, Inc. | 0.51%37.8K shares |
VANGUARD FIDUCIARY TRUST CO | 0.51%37.39K shares |
STERN ADAM K | —35.86K shares |
Nelson Steven Charles | —34.75K shares |
Leisure Lawrence B. | —32.9K shares |
Shaked Yoav | —32.89K shares |
Karah Hila | —30.97K shares |
Franco-Yehuda Chen | —30K shares |
MCGRATH DENNIS M | —27.74K shares |
Matheis Dennis | —27.63K shares |
CITADEL ADVISORS LLC | 0.33%24.29K shares |
NORTHERN TRUST CORP | 0.18%13.24K shares |
PALUMBO JOHN R | ≈0.06%4.5K shares |
Vanguard Global Advisers, LLC | 0.05%3.32K shares |
MORGAN STANLEY | 0.04%3K shares |
Percentages use 7.34M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Aug 27, 2025Form 4 | Nelson Steven CharlesPresident and CCO | BuyCommon Stock | 40.0K | $0.53 | $21.2K | 95.0K |
| Jan 7, 2025Form 4 | STERN ADAM KDirector | BuySeries D-2 Preferred Stock · derivative · indirect | 100 | $1.0K | $100.0K | 0 |
| Nov 12, 2024Form 4 | Nelson Steven CharlesChief Commercial Officer | BuyCommon Stock | 5.0K | $0.91 | $4.5K | 55.0K |
| Sep 11, 2024Form 4 | Nelson Steven CharlesChief Commercial Officer | BuyCommon Stock | 5.0K | $0.80 | $4.0K | 50.0K |
| Sep 10, 2024Form 4 | Nelson Steven CharlesChief Commercial Officer | BuyCommon Stock | 5.0K | $0.84 | $4.2K | 45.0K |